Intravesical Gemcitabine and Docetaxel Therapy for BCG-Naïve Patients: A Promising Approach to Non-Muscle Invasive Bladder Cancer

Bacillus Calmette-Guérin (BCG) therapy for patients with non-muscle invasive bladder cancer (NMIBC) faces limitations in efficacy and significant side effects, aggravated by a recent global shortage. In this prospective clinical study, we report the outcomes of sequential intravesical administration...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Life
المؤلفون الرئيسيون:	Mirko Bakula, Tvrtko Hudolin, Nikola Knezevic, Zoran Zimak, Jerko Andelic, Ilija Juric, Marija Gamulin, Milena Gnjidic, Zeljko Kastelan
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	MDPI AG 2024-06-01
الموضوعات:	BCG shortage non-muscle invasive bladder cancer BCG-naïve docetaxel gemcitabine
الوصول للمادة أونلاين:	https://www.mdpi.com/2075-1729/14/7/789

مواد مشابهة

Intravesical gemcitabine and docetaxel vs. re‐induction Bacillus Calmette Guerin as first‐line salvage therapy for non‐muscle invasive bladder cancer
حسب: Kylie Yen‐Yi Lim, وآخرون
منشور في: (2025-04-01)

Efficacy of intravesical gemcitabine instillation compared with intravesical Bacillus Calmette-Guérin instillation for non-muscle invasive bladder cancer
حسب: Dong Ha Kim, وآخرون
منشور في: (2024-12-01)

Pott's disease post intravesical BCG
حسب: Anika Jain
منشور في: (2023-01-01)

The efficacy of gemcitabine and docetaxel chemotherapy for the treatment of relapsed and refractory osteosarcoma: A systematic review and pre‐clinical study
حسب: Kaan Low, وآخرون
منشور في: (2024-09-01)

Psoriasis exacerbation following intravesical BCG immunotherapy for bladder carcinoma: A case report
حسب: Yusuf Can Edek, وآخرون
منشور في: (2025-07-01)

Pneumonitis secondary to intravesical Bacillus-Calmette-Guérin (BCG) immunotherapy
حسب: Komeil Alattar, MBBS, PGCert, وآخرون
منشور في: (2025-09-01)

Mycotic aortic aneurysms post-Intravesical BCG treatment for early-stage bladder carcinoma
حسب: Aman Wadhwani, وآخرون
منشور في: (2018-08-01)

Immune status of children with complications of BCG/BCG-M vaccination
حسب: T. A. Sevostyanova, وآخرون
منشور في: (2020-02-01)

After 100 Years of BCG Immunization against Tuberculosis, What Is New and Still Outstanding for This Vaccine?
حسب: Mario Alberto Flores-Valdez
منشور في: (2021-12-01)

Intravesical BCG: Possible Protective Impact Against COVID-19 in NMIBC Patients
حسب: Gabriel GLUCK, وآخرون
منشور في: (2020-06-01)

Bacillus Calmette-Guerin (BCG) infections following intravesical BCG immunotherapy: a systematic review protocol
حسب: Roberta Monardo, وآخرون
منشور في: (2025-01-01)

BCG and Alternative Therapies to BCG Therapy for Non-Muscle-Invasive Bladder Cancer
حسب: Sarah Lidagoster, وآخرون
منشور في: (2024-02-01)

Vaccination with a low dose of BCG or BCG∆BCG1419c protects against short-term Mycobacterium tuberculosis HN878 infection in male CB6F1 mice
حسب: Jorge Barrios-Payán, وآخرون
منشور في: (2025-07-01)

LEGAL BASIC OF BCG-THERAPY FOR BLADDER CANCER IN MUNICIPAL POLYCLINICS
حسب: M. M. Zorina, وآخرون
منشور في: (2016-10-01)

BCG vaccination strategies against tuberculosis: updates and perspectives
حسب: Mengjin Qu, وآخرون
منشور في: (2021-12-01)

Sequential intravesical Bacillus Calmette-Güerin and mitomycin C applied with electromotive drug administration therapy for non-muscle invasive bladder cancer
حسب: Mirko Bakula, وآخرون
منشور في: (2025-10-01)

Real‐world oncological and toxicity outcomes with the Moscow strain of intravesical BCG for non‐muscle invasive bladder cancer—Implications for global shortage
حسب: Amandeep Arora, وآخرون
منشور في: (2025-06-01)

Comparative analysis of genome-wide sequences of the seed lot of the vaccine strain of Mycobacterium bovis BCG-1 (Russia) and daughter isolates obtained from children with BCG osteitis
حسب: O. V. Narvskaya, وآخرون
منشور في: (2021-05-01)

Intravesical VSVd51-GM-CSF virotherapy is superior to BCG in treating bladder cancer in preclinical and translational models
حسب: Lauren Daniel, وآخرون
منشور في: (2025-09-01)

What have we learned after 30 years of BCG intravesical therapy for superficial bladder cancer?
حسب: Marcos Tobias-Machado, وآخرون
منشور في: (2009-12-01)

Vacina BCG contra tuberculose: efeito protetor e políticas de vacinação BCG vaccine against tuberculosis: its protective effect and vaccination policies
حسب: Susan M Pereira, وآخرون
منشور في: (2007-09-01)

Systematic Review and Meta-Analysis of Response Rates in BCG-unresponsive Non–Muscle-Invasive Bladder Cancer: a Consensus Statement From the International Bladder Cancer Group
حسب: Kyle M. Rose, وآخرون
منشور في: (2022-09-01)

When Bladder Cancer Treatment Strikes Back: Mycotic Aneurysms After Intravesical BCG Therapy
حسب: Sarah Blackwell, وآخرون
منشور في: (2025-10-01)

Intravesical High Dose BCG Tokyo and Low Dose BCG Tokyo with <i>GMCSF+IFN α </i> Induce Systemic Immunity in a Murine Orthotopic Bladder Cancer Model
حسب: Sin Mun Tham, وآخرون
منشور في: (2021-11-01)

Infantile BCG osteomyelitis ultimately diagnosed as a result of trauma
حسب: Katsuhiko Tabata, MD, وآخرون
منشور في: (2025-03-01)

Complete Genome Sequence, Genome Stability and Phylogeny of the Vaccine Strain <i>Mycobacterium bovis</i> BCG SL222 Sofia
حسب: Stefan Panaiotov, وآخرون
منشور في: (2021-03-01)

Protective role of intravesical BCG in COVID-19 severity
حسب: Héctor Gallegos, وآخرون
منشور في: (2021-03-01)

Two cases of disseminated BCG disease following vaccination in the same family: case reports and review of the literature in China
حسب: Jing Wang, وآخرون
منشور في: (2021-05-01)

Normas e Recomendações para o Emprego do BCG em Câncer
حسب: Humberto Torloni, وآخرون
منشور في: (2023-08-01)

Comparison of BCG Tokyo172 Strain Induction Therapy Between Low Dose and Standard Dose for Non-Muscle Invasive Bladder Cancer: Intravesical Instillation of BCG Tokyo172 Strain
حسب: Hideyuki Isobe, وآخرون
منشور في: (2025-01-01)

BCG-SSI® vaccine-associated lymphadenitis: Incidence and management
حسب: Arnis Engelis, وآخرون
منشور في: (2016-01-01)

Impact of intravesical Bacillus Calmette-Guérin and chemotherapy on the bladder microbiome in patients with non-muscle invasive bladder cancer
حسب: Christopher James, وآخرون
منشور في: (2023-04-01)

The efficacy and safety of gemcitabine and docetaxel in pseudomyogenic hemangioendothelioma: a multi-center experience
حسب: Qiyan Cai, وآخرون
منشور في: (2025-07-01)

Auxotrophic <i>Mycobacterium bovis</i> BCG: Updates and Perspectives
حسب: Odir Antônio Dellagostin, وآخرون
منشور في: (2022-05-01)

Update on the Mechanism of Action of Intravesical BCG Therapy to Treat Non-Muscle-Invasive Bladder Cancer
حسب: Mohamad Abou Chakra, وآخرون
منشور في: (2024-08-01)

Comparison of the efficacy of BCG intravesical immunotherapy using the conventional Rotisserie method with the non-Rotisserie method
حسب: Mohammad Kazem Hariri, وآخرون
منشور في: (2023-10-01)

COVID-19 Infection and Previous BCG Vaccination Coverage in the Ecuadorian Population
حسب: Daniel Garzon-Chavez, وآخرون
منشور في: (2021-01-01)

Analysis of three cases of disseminated BCG infection in infants after BCG vaccination in Beijing, China
حسب: Li Li, وآخرون
منشور في: (2025-12-01)

Um caso de adenite por BCG
حسب: Marta Sousa Tavares, وآخرون
منشور في: (2014-09-01)

Fighting Tuberculosis: In Search of a BCG Replacement
حسب: Nonna I. Nadolinskaia, وآخرون
منشور في: (2022-12-01)